CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Friday reported a loss of $1.12 billion in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $2.91. Losses, adjusted for non-recurring costs, were $2.50 per share.
The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of $2.69 per share.
The biotechnology company posted revenue of $966 million in the period, which also beat Street forecasts. Nine analysts surveyed by Zacks expected $956.1 million.
For the year, the company reported a loss of $3.56 billion, or $9.28 per share. Revenue was reported as $3.24 billion.
Moderna expects full-year revenue in the range of $1.5 billion to $2.5 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
